IL98990A - History of their manufacture and the pharmaceutical preparations containing them - Google Patents

History of their manufacture and the pharmaceutical preparations containing them

Info

Publication number
IL98990A
IL98990A IL9899091A IL9899091A IL98990A IL 98990 A IL98990 A IL 98990A IL 9899091 A IL9899091 A IL 9899091A IL 9899091 A IL9899091 A IL 9899091A IL 98990 A IL98990 A IL 98990A
Authority
IL
Israel
Prior art keywords
alkyl
hydrogen
compound
mmol
indole
Prior art date
Application number
IL9899091A
Other languages
English (en)
Hebrew (he)
Other versions
IL98990A0 (en
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016790A external-priority patent/GB9016790D0/en
Priority claimed from GB919107486A external-priority patent/GB9107486D0/en
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of IL98990A0 publication Critical patent/IL98990A0/xx
Publication of IL98990A publication Critical patent/IL98990A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9899091A 1990-07-31 1991-07-29 History of their manufacture and the pharmaceutical preparations containing them IL98990A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016790A GB9016790D0 (en) 1990-07-31 1990-07-31 Pharmaceutical compounds
GB919107486A GB9107486D0 (en) 1991-04-09 1991-04-09 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
IL98990A0 IL98990A0 (en) 1992-07-15
IL98990A true IL98990A (en) 1995-06-29

Family

ID=26297410

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9899091A IL98990A (en) 1990-07-31 1991-07-29 History of their manufacture and the pharmaceutical preparations containing them

Country Status (24)

Country Link
EP (1) EP0469833B1 (fr)
JP (1) JP3220191B2 (fr)
KR (1) KR0179985B1 (fr)
CN (1) CN1040108C (fr)
AT (1) ATE184280T1 (fr)
AU (1) AU654140B2 (fr)
CA (1) CA2048096C (fr)
CZ (1) CZ279932B6 (fr)
DE (1) DE69131592T2 (fr)
DK (1) DK0469833T3 (fr)
ES (1) ES2137158T3 (fr)
FI (1) FI102536B (fr)
GR (1) GR3032038T3 (fr)
HU (2) HU213604B (fr)
IE (1) IE912670A1 (fr)
IL (1) IL98990A (fr)
MX (1) MX9100414A (fr)
MY (1) MY131141A (fr)
NO (1) NO300133B1 (fr)
NZ (1) NZ239168A (fr)
PH (1) PH30487A (fr)
PT (1) PT98475B (fr)
SK (1) SK279197B6 (fr)
YU (1) YU47839B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
US5273986A (en) * 1992-07-02 1993-12-28 Hoffmann-La Roche Inc. Cycloalkylthiazoles
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
GB9523948D0 (en) * 1995-11-23 1996-01-24 Univ East Anglia Process for preparing n-benzyl indoles
US6160120A (en) 1996-11-19 2000-12-12 Eli Lilly And Company Process for preparing n-benzyl indoles
AU2005295821A1 (en) * 2004-10-12 2006-04-27 Decode Genetics Ehf Carboxylic acid peri - substituted bicyclics for occlusive artery disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
US4970207A (en) * 1988-07-07 1990-11-13 Fujisawa Pharmaceutical Company, Ltd. Benzodiazepine derivatives

Also Published As

Publication number Publication date
DE69131592D1 (de) 1999-10-14
DK0469833T3 (da) 1999-12-20
MY131141A (en) 2007-07-31
CN1040108C (zh) 1998-10-07
EP0469833B1 (fr) 1999-09-08
NZ239168A (en) 1993-05-26
PT98475B (pt) 1997-11-28
YU47839B (sr) 1996-01-09
NO912963L (no) 1992-02-03
NO912963D0 (no) 1991-07-30
GR3032038T3 (en) 2000-03-31
ES2137158T3 (es) 1999-12-16
HUT60491A (en) 1992-09-28
EP0469833A1 (fr) 1992-02-05
SK279197B6 (sk) 1998-07-08
IL98990A0 (en) 1992-07-15
FI102536B1 (fi) 1998-12-31
AU654140B2 (en) 1994-10-27
CS238091A3 (en) 1992-03-18
KR0179985B1 (ko) 1999-03-20
CN1061413A (zh) 1992-05-27
HU213604B (en) 1997-08-28
NO300133B1 (no) 1997-04-14
CA2048096A1 (fr) 1992-02-01
AU8139991A (en) 1992-02-06
YU132591A (sh) 1994-01-20
HU912535D0 (en) 1992-01-28
DE69131592T2 (de) 2000-01-20
ATE184280T1 (de) 1999-09-15
PH30487A (en) 1997-05-28
MX9100414A (es) 1992-02-28
CZ279932B6 (cs) 1995-08-16
FI102536B (fi) 1998-12-31
FI913639A (fi) 1992-02-01
HU211952A9 (en) 1996-01-29
JP3220191B2 (ja) 2001-10-22
FI913639A0 (fi) 1991-07-30
KR920002582A (ko) 1992-02-28
CA2048096C (fr) 2002-09-17
IE912670A1 (en) 1992-02-12
PT98475A (pt) 1992-06-30
JPH06220045A (ja) 1994-08-09

Similar Documents

Publication Publication Date Title
JP2722279B2 (ja) アミノメチレンで置換した非芳香族複素環式化合物及びサブスタンスｐのアンタゴニストとしての使用
US5273986A (en) Cycloalkylthiazoles
JP3120873B2 (ja) ピリジン誘導体
US5410061A (en) Pharmaceutical compounds
JPH0625134B2 (ja) 新規な複素環化合物
US5364865A (en) Phenoxy- and phenoxyalkyl-piperidines as antiviral agents
JPH0559042A (ja) 化学的方法
US7094779B2 (en) Piperazine oxime dervatives having NK-1 receptor antagonistic activity
JP2740251B2 (ja) 炭素環式アミド、その製造法、中間体、および該化合物を含有するアレルギー性疾患および炎症性疾患を治療するための製薬学的組成物
US5846965A (en) 3-aza and 3-oxa piperidone tachykinin antagonists
EP0469833B1 (fr) N-Benzyl-Indoles, procédés pour leur préparation et compositions pharmaceutiques les contenant
AU2002333229A1 (en) Piperazine oxime derivatives having NK-1 receptor antagonistic activity
US5281593A (en) Certain indole derivatives useful as leukotriene antagonists
DK169104B1 (da) Analogifremgangsmåde til fremstilling af N-substituerede 2-pyridylindoler eller salte deraf
JPH04257578A (ja) 複素環置換されたシクロアルカノ〔ｂ〕−インドールスルホンアミド
US5607957A (en) Imidazole, triazole and tetrazole derivatives
US5334718A (en) Chemical process and intermediates used therein
US5622969A (en) Method of treating leukotriene caused diseases with N-benzyl dihydroindole LTD4 antagonists
US5807866A (en) Process for preparing N-benzyl indoles
JP6426697B2 (ja) 尿素誘導体及びその脂肪酸結合タンパク質（ｆａｂｐ）阻害剤としての使用
US5155130A (en) Certain benzopyran and benzothiopyran derivatives
Sawyer et al. N-benzyl dihydroindole LTD 4 antagonists
JPH03291280A (ja) チオクロモン誘導体

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees